Literature DB >> 3470705

Urinary excretion of lactate, 2-oxoglutarate, citrate, and glycerol in patients with glycogenosis type I.

J Fernandes, R Berger.   

Abstract

Growth retardation and lactic aciduria are well-known abnormalities in patients with a deficiency of either glucose-6-phosphatase or glucose-6-phosphate translocase. In 19 patients with glucose-6-phosphatase and two patients with glucose-6-phosphate translocase, growth retardation was quantified by calculating the height standard deviation score. The urinary excretion of lactate and some other metabolites was quantified by calculating the lactate/creatinine, 2-oxoglutarate/creatinine, citrate/creatinine, and glycerol/creatinine ratios in urine. Significant correlations were found between the lactate/creatinine ratio, the 2-oxoglutarate/creatinine ratio, and height SD score. Urinary lactate appeared to respond promptly to changes of the diet, while urinary 2-oxoglutarate responded only slowly, as did growth itself. The citrate/creatinine ratio and the glycerol/creatinine ratio were within the normal range and varied little. It was concluded that the urinary 2-oxoglutarate excretion primarily reflects the severity of the disease as expressed in stunted growth. Thus, while urinary lactate levels are more suitable for monitoring the diet, urinary 2-oxoglutarate levels can be used as an indication for intensive treatment with hyperalimentation.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3470705     DOI: 10.1203/00006450-198703000-00015

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  6 in total

1.  Urinary lactate excretion in type 1 glycogenosis--a marker of metabolic control or renal tubular dysfunction?

Authors:  P J Lee; C Chatterton; J V Leonard
Journal:  J Inherit Metab Dis       Date:  1996       Impact factor: 4.982

Review 2.  Glycogen storage disease: recommendations for treatment.

Authors:  J Fernandes; J V Leonard; S W Moses; M Odièvre; M di Rocco; J Schaub; G P Smit; K Ullrich; P Durand
Journal:  Eur J Pediatr       Date:  1988-04       Impact factor: 3.183

3.  Metabolic control and renal dysfunction in type I glycogen storage disease.

Authors:  J I Wolfsdorf; L M Laffel; J F Crigler
Journal:  J Inherit Metab Dis       Date:  1997-08       Impact factor: 4.982

4.  Treatment with low-dose diazoxide in two growth-retarded prepubertal girls with glycogen storage disease type Ia resulted in catch-up growth.

Authors:  J M Nuoffer; P E Mullis; U N Wiesmann
Journal:  J Inherit Metab Dis       Date:  1997-11       Impact factor: 4.982

5.  Untargeted plasma metabolomics identifies broad metabolic perturbations in glycogen storage disease type I.

Authors:  Tamara Mathis; Martin Poms; Harald Köfeler; Matthias Gautschi; Barbara Plecko; Matthias R Baumgartner; Michel Hochuli
Journal:  J Inherit Metab Dis       Date:  2021-11-10       Impact factor: 4.750

6.  Health effects of kiwi wine on rats: an untargeted metabolic fingerprint study based on GC-MS/TOF.

Authors:  Qi Zeng; Hongjin Song; Xinyi Xu; Wenjie Mao; Hui Xie; Jimin Liang; Xueli Chen; Dan Chen; Yonghua Zhan
Journal:  RSC Adv       Date:  2019-05-03       Impact factor: 4.036

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.